On 6 May 2026, Cofoe Medical Technology Co., Ltd. (Cofoe Medical, 1187.HK) successfully listed on the Main Board of the Hong Kong Stock Exchange (HKEx), raising a total of approximately HKD 1.06 billion. CBI is honored to participate in the due diligence work for this IPO Project.

Cofoe Medical is primarily engaged in the research and development, manufacturing and sales of home care medical devices. The Company's products mainly cover five areas including rehabilitation aids products, medical care products, health monitoring products, respiratory support products and others.

In this IPO project, CBI primarily assisted the sponsor team in conducting due diligence on the company group, its directors, senior management, shareholders, customers and suppliers, etc. In addition to the basic information such as litigation, bankruptcy, winding-up and media records, CBI also assisted the sponsor team in conducting reputation intelligence and related company search. The due diligence project globally covered 5 countries and regions, including China, Hong Kong, Singapore and Malaysia, etc.